The prevalence of hypertension, diabetes, metabolic syndrome, cardiovascular disease and decreased GFR according to the following age groups: 60–69, 70–79 and ≥80 years. by Regina C. R. M. Abdulkader (302450)

“…Diabetes mellitus: self-reported or a fasting plasma glucose ≥126 mg/dL or a glycohemoglobin ≥6.5%. …”

Cre-mediated activation of RIαB allele specifically in the liver decreases PKA activity in vivo. by Brandon S. Willis (353418)

Mass Spectrometry Experiment 2 and 3: Comparison of Vpu WT and mutants. by Charlotte A. Stoneham (10819125)

PGRN deletion decreased the susceptibility to invasive <i>C</i>.<i>albicans</i> infection in mice. by Jiayu Liu (3951515)

Phosphorylation of Akt (Ser473) is decreased in Ric-8B^bgeo/bgeo embryos. by Maíra H. Nagai (8822732)

Decreased alveolar levels of TNF-α and IL-6R levels in ADAM17-null mice. by Patrick G. Arndt (351620)

Reduction of GC B cells decreases the number of Tfh cells in NZB/W F1 mice. by Isharat Yusuf (354734)

The transcript and protein abundances of several VAC-residing proteases were decreased in Δ<i>crt</i>. by L. Brock Thornton (6808385)

Effect of decreased K8 Ser 73 or Ser431 phosphorylation on migratory ability of OSCC cells. by Hunain Alam (103978)

Reducing Dscam1 diversity decreases adult lifespan in an exon-specific manner, Related to Fig 3. by Haiyang Dong (4783608)

Decreased naive CD4 and CD8 T cells with increased apoptosis in Rasal3-KO mice. by Ryunosuke Muro (707582)

Increased DNA methyltransferase gene expression in prostate cancer cell lines was decreased with SFN or DIM treatments. by Carmen P. Wong (512550)

Hormone therapy decreased β-amyloid load and improved cognitive performance in early middle-aged mice. by Amy Christensen (4062937)

The NK1-receptor antagonist ezlopitant significantly decreases voluntary intake of non-caloric saccharin solution. by Pia Steensland (362091)

“…<p>Ezlopitant (5 and 10 mg/kg) significantly decreased consumption of the non-caloric 0.2% saccharin solution compared to vehicle. …”

The NK1-receptor antagonist ezlopitant significantly and selectively decreases voluntary intake of both sucrose and ethanol. by Pia Steensland (362091)

“…<p>Ezlopitant decreased consumption of 5% sucrose (<b>A</b>), whereas only the highest dose of ezlopitant (10 mg/kg) decreased consumption of 20% ethanol (<b>B</b>). …”

Cell migration speed is decreased on 500 nm versus 2000 nm RGD-coupled gold squares. by Roman Lutz (203730)

Administration of anti-DJ-1 antibody decreased the inflammatory cytokine expression and attenuated ischemic neuronal injury. by Koutarou Nakamura (10833014)

Loss of <i>SLC4A11</i> expression and CHED-associated <i>SLC4A11</i> mutations in hCEnC lead to decreased cell viability during tBH-induced oxidative stress. by Doug D. Chung (3611387)

HIF^C neutrophils have increased levels of apoptosis and necrosis and decreased endothelial attachment. by Kelly M. Shepardson (404375)

Activated B Cells Are Decreased in the Lungs and Spleens of IκBαM-Infected Mice by Laurie T Krug (68237)